| Authors: |
Sridhar S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, UK., Forrest S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Kean I; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Young J; Department of Medical Genetics, University of Cambridge, Cambridge, UK., Bartholdson Scott J; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Maes M; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Pereira-Dias J; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Parmar S; Public Health England Diagnostic Laboratory, Addenbrooke's Hospital, Cambridge, UK., Routledge M; Infectious Diseases, Addenbrooke's Hospital, Cambridge, UK., Sparkes D; Infectious Diseases, Addenbrooke's Hospital, Cambridge, UK., Rivett L; Infectious Diseases, Addenbrooke's Hospital, Cambridge, UK., Dougan G; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Weekes M; Infectious Diseases, Addenbrooke's Hospital, Cambridge, UK., Curran M; Public Health England Diagnostic Laboratory, Addenbrooke's Hospital, Cambridge, UK., Goodfellow I; Division of Virology, Department of Pathology, University of Cambridge, Cambridghe, UK., Baker S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK. |
